Nima Rezaei

107.0k total citations · 10 hit papers
1.2k papers, 26.4k citations indexed

About

Nima Rezaei is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Nima Rezaei has authored 1.2k papers receiving a total of 26.4k indexed citations (citations by other indexed papers that have themselves been cited), including 489 papers in Immunology, 197 papers in Genetics and 196 papers in Molecular Biology. Recurrent topics in Nima Rezaei's work include Immunodeficiency and Autoimmune Disorders (271 papers), Blood disorders and treatments (121 papers) and Immune Cell Function and Interaction (114 papers). Nima Rezaei is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (271 papers), Blood disorders and treatments (121 papers) and Immune Cell Function and Interaction (114 papers). Nima Rezaei collaborates with scholars based in Iran, United States and India. Nima Rezaei's co-authors include Amene Saghazadeh, Asghar Aghamohammadi, Michael R. Hamblin, Hassan Abolhassani, Melika Lotfi, Mahsa Keshavarz‐Fathi, Niloufar Yazdanpanah, Sepideh Razi, Farzaneh Rahmani and Shaghayegh Khanmohammadi and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Genetics.

In The Last Decade

Nima Rezaei

1.1k papers receiving 25.9k citations

Hit Papers

COVID-19: Transmission, p... 2009 2026 2014 2020 2020 2009 2021 2020 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. COVID-19: Transmission, prevention, and potential therapeutic opportunities
    2020 606 citations Nima Rezaei et al. profile →
  2. A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
    2009 574 citations Mohammad Nabavi, Nima Rezaei et al. profile →
  3. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes
    2021 333 citations Amene Saghazadeh, Nima Rezaei et al. profile →
  4. COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being
    2020 283 citations Nima Rezaei et al. profile →
  5. Role of Toll‐like receptors in the pathogenesis of COVID‐19
    2021 278 citations Nima Rezaei et al. profile →
  6. The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
    2022 170 citations Niloufar Yazdanpanah, Nima Rezaei et al. profile →
  7. Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives
    2024 63 citations Nima Rezaei et al. profile →
  8. The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons
    2024 40 citations Seyed Aria Nejadghaderi, Nima Rezaei et al. Health Science Reports profile →
  9. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee
    2025 40 citations Anne Puel, Nima Rezaei et al. profile →
  10. The 2024 update of IUIS phenotypic classification of human inborn errors of immunity
    2025 16 citations Anne Puel, Nima Rezaei et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Nima Rezaei 9.2k 5.1k 4.6k 3.3k 3.1k 1.2k 26.4k
Paul Emery 18.2k 2.0× 5.8k 1.1× 1.7k 0.4× 2.6k 0.8× 3.7k 1.2× 1.0k 67.0k
Michael E. Weinblatt 7.4k 0.8× 4.9k 1.0× 1.0k 0.2× 5.1k 1.5× 2.3k 0.7× 381 33.9k
Mauro Martins Teixeira 9.2k 1.0× 10.5k 2.1× 3.4k 0.7× 1.4k 0.4× 6.0k 2.0× 768 32.6k
Xuan Zhang 5.1k 0.5× 7.9k 1.5× 1.5k 0.3× 1.2k 0.3× 2.5k 0.8× 868 22.7k
Lars Klareskog 13.8k 1.5× 6.1k 1.2× 953 0.2× 3.7k 1.1× 3.1k 1.0× 657 42.3k
Gerd R Burmester 8.8k 1.0× 3.4k 0.7× 1.4k 0.3× 1.4k 0.4× 1.8k 0.6× 596 28.3k
Demetrios�� Spandidos 2.7k 0.3× 10.3k 2.0× 2.4k 0.5× 2.3k 0.7× 3.2k 1.0× 973 27.1k
Yehuda Shoenfeld 20.2k 2.2× 8.2k 1.6× 5.5k 1.2× 6.2k 1.8× 7.9k 2.6× 1.6k 63.1k
Cisca Wijmenga 5.9k 0.6× 15.3k 3.0× 2.6k 0.6× 7.4k 2.2× 4.4k 1.4× 408 32.1k
Cezmi A. Akdiş 12.1k 1.3× 5.1k 1.0× 5.2k 1.1× 1.0k 0.3× 2.0k 0.6× 500 42.6k

Countries citing papers authored by Nima Rezaei

Since Specialization
Citations

This map shows the geographic impact of Nima Rezaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nima Rezaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nima Rezaei more than expected).

Fields of papers citing papers by Nima Rezaei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nima Rezaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nima Rezaei. The network helps show where Nima Rezaei may publish in the future.

Co-authorship network of co-authors of Nima Rezaei

This figure shows the co-authorship network connecting the top 25 collaborators of Nima Rezaei. A scholar is included among the top collaborators of Nima Rezaei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nima Rezaei. Nima Rezaei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salami, Fereshte, Nazanin Fathi, Sepideh Shahkarami, et al.. (2025). ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects. Journal of Clinical Immunology. 45(1). 67–67.
2.
Saleki, Kiarash, et al.. (2024). The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management. Medicinal Research Reviews. 44(3). 1267–1325. 25 indexed citations
3.
Yazdanpanah, Niloufar, et al.. (2024). Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments. Advances in Rheumatology. 64(1). 61–61. 3 indexed citations
4.
Nejadghaderi, Seyed Aria, et al.. (2024). The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons. Health Science Reports. 7(6). e2165–e2165. 40 indexed citations breakdown →
5.
Rezaei, Nima, et al.. (2024). Enhancing breast cancer surgery outcomes: A comprehensive review of oncoplastic techniques, surgical planning, and aesthetic considerations. Critical Reviews in Oncology/Hematology. 206. 104578–104578. 2 indexed citations
6.
Mahmoudi, Mohammad, Nazanin Mojtabavi, Farshid Noorbakhsh, et al.. (2024). Enhancing the anti-tumor activity and reprogramming M2 macrophages by delivering siRNAs against SIRPα and STAT6 via M1 exosomes and combining with anti-PD-L1. Life Sciences. 361. 123311–123311. 2 indexed citations
7.
Pezeshki, Parmida Sadat, et al.. (2023). Whole‐exome sequencing to identify undiagnosed primary immunodeficiency disorders in children with community‐acquired sepsis, admitted in the pediatric intensive care unit. Pediatric Allergy and Immunology. 34(12). e14066–e14066. 2 indexed citations
8.
Mahdaviani, Seyed Alireza, et al.. (2023). Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome. BMC Surgery. 23(1). 289–289. 2 indexed citations
9.
Hosseini, Mina, et al.. (2023). Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review. Vaccines. 11(1). 146–146. 27 indexed citations
10.
Sadeghalvad, Mona, Sepideh Shahkarami, Samaneh Zoghi, et al.. (2023). A novel X-linked mutation in IL2RG associated with early-onset inflammatory bowel disease: a case report of twin brothers. Journal of Medical Case Reports. 17(1). 307–307.
11.
Sharifinejad, Niusha, Gholamreza Azizi, Zahra Chavoshzadeh, et al.. (2023). Autoimmune versus Non-autoimmune Cutaneous Features in Monogenic Patients with Inborn Errors of Immunity. Biology. 12(5). 644–644. 4 indexed citations
12.
Rezaei, Nima & Sara Hanaei. (2023). Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1. Advances in experimental medicine and biology. 2 indexed citations
13.
Hamidieh, Amir Ali, Maryam Behfar, Mahmood Bozorgmehr, et al.. (2023). Disturbance in the reconstitution of distinct T-cell subsets and the incidence of GvHD following allo-HSCT in pediatric patients with non-malignant hematological disorders. Immunology Letters. 261. 25–36. 2 indexed citations
14.
15.
Hamidieh, Amir Ali, Maryam Behfar, Amene Saghazadeh, et al.. (2023). Unbalanced T-cell subsets in pediatric patients with beta-thalassemia. Human Immunology. 84(3). 224–234. 3 indexed citations
16.
Safari, Tahereh, et al.. (2021). The Effect of Influenza Vaccination on COVID-19 Morbidity, Severity and Mortality: Systematic Review and Meta-Analysis. Malaysian Journal of Medical Sciences. 28(6). 20–31. 15 indexed citations
17.
Hanaei, Sara, et al.. (2020). Association of interleukin 2, interleukin 12, and interferon-γ with intervertebral disc degeneration in Iranian population. BMC Medical Genetics. 21(1). 10 indexed citations
18.
Azizi, Gholamreza, Abbas Mirshafiey, Hassan Abolhassani, et al.. (2018). The imbalance of circulating T helper subsets and regulatory T cells in patients with LRBA deficiency: Correlation with disease severity. Journal of Cellular Physiology. 233(11). 8767–8777. 18 indexed citations
19.
Monajemzadeh, Maryam, Soheila Sarmadi, Maryam Moeini, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 7. 348–348. 1 indexed citations
20.
Mahmoudi, Mahmood, Fereydoun Siassi, Mahmood Mahmoudi, et al.. (2011). In vitro Effect of oxLDL and PHA on Lymphocyte Proliferation/Cytotoxicity and Interleukin-2 Production in Patients with Atherosclerosis. Journal of Allergy and Clinical Immunology. 127(2). AB232–AB232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Emery Breakdown of academic impact, for papers by Michael E. Weinblatt Breakdown of academic impact, for papers by Mauro Martins Teixeira Breakdown of academic impact, for papers by Xuan Zhang Breakdown of academic impact, for papers by Lars Klareskog Breakdown of academic impact, for papers by Gerd R Burmester Breakdown of academic impact, for papers by Demetrios�� Spandidos Breakdown of academic impact, for papers by Yehuda Shoenfeld Breakdown of academic impact, for papers by Cisca Wijmenga Breakdown of academic impact, for papers by Cezmi A. Akdiş
Rankless by CCL
2026